NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Update

NewGenIvf Group Limited (NASDAQ:NIVF) saw a significant decline in short interest during the month of August. As of August 31st, there was short interest totaling 91,719 shares, a decline of 46.6% from the August 15th total of 171,641 shares. Based on an average daily volume of 672,683 shares, the short-interest ratio is currently 0.1 days. Currently, 6.4% of the shares of the stock are short sold.

Analysts Set New Price Targets

Several equities analysts recently issued reports on NIVF shares. Wall Street Zen raised shares of NewGenIvf Group to a “hold” rating in a report on Saturday, July 4th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of NewGenIvf Group in a research report on Friday, July 24th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

Insider Buying and Selling at NewGenIvf Group

In related news, Director Kong Yiu Cheung acquired 2,500,000 shares of the stock in a transaction dated Monday, July 27th. The stock was acquired at an average cost of $1.00 per share, with a total value of $2,500,000.00. Following the purchase, the director directly owned 3,722,223 shares of the company’s stock, valued at approximately $3,722,223. This trade represents a 204.55% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 31.80% of the stock is currently owned by company insiders.

NewGenIvf Group Trading Down 7.1%

Shares of NIVF stock traded down $0.06 during mid-day trading on Thursday, hitting $0.73. 37,019 shares of the stock were exchanged, compared to its average volume of 281,813. NewGenIvf Group has a 52-week low of $0.71 and a 52-week high of $1,539.00. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16. The firm has a fifty day moving average of $2.17 and a 200 day moving average of $9.17.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.